During the past decade, Università degli Studi di Padova - Ematologia ed Immunologia Clinica conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università degli Studi di Padova - Ematologia ed Immunologia Clinica" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Università degli Studi di Padova - Ematologia ed Immunologia Clinica" are "Chronic Lymphocytic Leukemia" (3 trials), "Chronic Myeloid Leukemia" (3 trials), "Non-Hodgkin's Lymphoma" (3 trials), "Acute Myeloid Leukemia" (2 trials) and "BCR-ABL Positive" (2 trials). Many other conditions were trialed in "Università degli Studi di Padova - Ematologia ed Immunologia Clinica" in a lesser frequency.

Most popular intervention types in "Università degli Studi di Padova - Ematologia ed Immunologia Clinica" are "Drug" (19 trials), "Other" (2 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "Nilotinib" (3 trials), "rituximab [MabThera/Rituxan]" (3 trials), "Cyclophosphamide" (2 trials) and "Ibrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Università degli Studi di Padova - Ematologia ed Immunologia Clinica" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Università degli Studi di Padova - Ematologia ed Immunologia Clinica". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Università degli Studi di Padova - Ematologia ed Immunologia Clinica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Università degli Studi di Padova - Ematologia ed Immunologia Clinica, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".